Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
PUT
Upbound Group
UPBD
$1.14B
| $150K | ﹤0.01% |
10,200
+6,100
| +149% | +$66.1K |
|
|
LUMO
4877
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $150K | ﹤0.01% |
3,515
-3,987
| -53% | -$183K |
|
|
ZYNE
4878
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $150K | ﹤0.01% |
15,400
-1,094
| -7% | -$11.2K |
|
|
XENT
4879
DELISTED
Intersect ENT, Inc
XENT
| $150K | ﹤0.01% |
4,013
-2,112
| -34% | -$82.9K |
|
|
AIMT
4880
DELISTED
Aimmune Therapeutics
AIMT
| $150K | ﹤0.01% |
5,546
-18,779
| -77% | -$575K |
|
4881
Anavex Life Sciences
AVXL
$304M
| $149K | ﹤0.01% |
57,030
+48,850
| +597% | +$136K |
|
4882
Icahn Enterprises
IEP
$5.42B
| $149K | ﹤0.01% |
2,092
+2,035
| +3,570% | +$137K |
|
4883
Novanta
NOVT
$5.82B
| $149K | ﹤0.01% |
2,399
-5,223
| -69% | -$319K |
|
4884
Cactus
WHD
$5.5B
| $149K | ﹤0.01% |
4,408
-57,942
| -93% | -$1.79M |
|
4885
Akebia Therapeutics
AKBA
$264M
| $148K | ﹤0.01% |
14,805
-16,340
| -52% | -$164K |
|
|
WCG
4886
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $148K | ﹤0.01% |
600
-1,100
| -65% | -$240K |
|
4887
DHI Group
DHX
$179M
| $147K | ﹤0.01% |
62,580
+21,173
| +51% | +$42.9K |
|
4888
Harmonic Inc
HLIT
$1.27B
| $147K | ﹤0.01% |
34,728
+9,697
| +39% | +$38.1K |
|
4889
CALL
Paylocity
PCTY
$8.04B
| $147K | ﹤0.01% |
+2,500
| New | +$143K |
|
4890
CALL
Marriott Vacations Worldwide
VAC
$4.28B
| $147K | ﹤0.01% |
1,300
-800
| -38% | -$98.9K |
|
|
CTT
4891
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $147K | ﹤0.01% |
11,497
-9,327
| -45% | -$120K |
|
|
PS
4892
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $147K | ﹤0.01% |
+6,020
| New | +$145K |
|
4893
Baytex Energy
BTE
$2.89B
| $146K | ﹤0.01% |
43,769
| – | – |
|
4894
Cenovus Energy
CVE
$52.1B
| $146K | ﹤0.01% |
14,099
-190,851
| -93% | -$1.92M |
|
4895
CALL
InterDigital
IDCC
$8.47B
| $146K | ﹤0.01% |
1,800
-8,200
| -82% | -$652K |
|
4896
Sunrun
RUN
$2.26B
| $146K | ﹤0.01% |
11,167
-17,692
| -61% | -$192K |
|
|
ACHN
4897
DELISTED
Achillion Pharmaceuticals
ACHN
| $146K | ﹤0.01% |
51,529
-10,769
| -17% | -$36.7K |
|
4898
CALL
Camping World
CWH
$644M
| $145K | ﹤0.01% |
+5,800
| New | +$145K |
|
|
EARN
4899
Ellington Residential Mortgage REIT
EARN
$163M
| $145K | ﹤0.01% |
13,328
+11,433
| +603% | +$129K |
|
4900
PUT
Fortune Brands Innovations
FBIN
$6.01B
| $145K | ﹤0.01% |
3,159
-16,029
| -84% | -$777K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.